Rating Change
Citigroup reiterated its Buy rating on Roivant Sciences Ltd. (NASDAQ:ROIV) on October 28, 2026.
reiterateNASDAQ:ROIV
Citigroup Reiterates Buy Rating on Roivant Sciences Ltd. (ROIV)
Citigroup reiterated its Buy rating on Roivant Sciences Ltd. (NASDAQ:ROIV) on October 28, 2026.
At publication ·
What changed
Roivant Sciences Ltd. (NASDAQ:ROIV) · reiterate
- Firm
- Citigroup
- Rating
- Buy to Buy
- Price at event
- $37.11
- Market capitalization
- $14.8B
At a glance
Key takeaways
- Citigroup reiterated a Buy rating on Roivant Sciences (ROIV) on October 28, 2026, with the stock trading at $37.11 and a market capitalization of $14.8 billion.
Market Context
Roivant Sciences Ltd. operates in the Healthcare sector. The stock currently trades at $37.11 with a market capitalization of $14.8B. The stock has gained 85.6% over the past 52 weeks.
Analyst coverage from Citigroup provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Roivant Sciences Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Roivant Sciences Ltd.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 28, 2026 | Citigroup | Buy | N/A |
| Oct 12, 2026 | Wolfe Research | Peer Perform | N/A |
| Sep 17, 2026 | Stifel | Buy | N/A |
| Sep 09, 2026 | TD Cowen | Buy | N/A |
| Sep 09, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ROIV Stock Page
Frequently Asked Questions
What does the Buy rating mean for ROIV?
A rating of Buy from Citigroup reflects the analyst's outlook on Roivant Sciences Ltd. (NASDAQ:ROIV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ROIV forecast page.